Low-Dose Radiation Therapy (LDRT) for COVID-19: Benefits or Risks?

The limited impact of treatments for COVID-19 has stimulated several Phase 1 clinical trials of whole-lung low-dose radiation therapy (LDRT; 0.3 – 1.5 Gy) that are now proceeding to Phase 2 randomized trials worldwide. This novel but unconventional use of radiation to treat COVID-19 prompted the Nat...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Radiat Res
Main Authors: Prasanna, Pataje G., Woloschak, Gayle E., DiCarlo, Andrea L., Buchsbaum, Jeffrey C., Schaue, Dörthe, Chakravarti, Arnab, Cucinotta, Francis A., Formenti, Silvia C., Guha, Chandan, Hu, Dale J., Khan, Mohammad K., Kirsch, David G., Krishnan, Sunil, Leitner, Wolfgang W., Marples, Brian, McBride, William, Mehta, Minesh P., Rafii, Shahin, Sharon, Elad, Sullivan, Julie M., Weichselbaum, Ralph R., Ahmed, Mansoor M., Vikram, Bhadrasain, Coleman, C. Norman, Held, Kathryn D.
Formato: Artigo
Idioma:Inglês
Publicado em: 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8009137/
https://ncbi.nlm.nih.gov/pubmed/33045077
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1667/RADE-20-00211.1
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados